Sigyn Therapeutics, Inc.
SIGY
$4.15
$0.153.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.43% | -4.30% | -1.45% | 0.83% | -41.51% |
| Total Depreciation and Amortization | -35.23% | -23.08% | -46.72% | -31.86% | -15.38% |
| Total Amortization of Deferred Charges | -58.04% | -27.77% | -30.20% | -13.80% | 160.98% |
| Total Other Non-Cash Items | 348.22% | 400.87% | 158.17% | -660.83% | -- |
| Change in Net Operating Assets | 48.72% | 317.89% | 876.77% | 1,519.12% | 177.00% |
| Cash from Operations | 36.93% | 58.40% | 51.25% | 45.37% | 24.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -29.03% | -50.29% | -49.57% | -65.02% | -11.17% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 100.00% | 91.97% |
| Cash from Financing | -37.04% | -53.52% | -50.07% | -64.74% | -7.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.24% | 174.25% | 84.05% | -220.17% | 101.02% |